Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality.

Kim J, Gregson DB, Ross T, Laupland KB.

J Infect. 2010 Sep;61(3):197-204. doi: 10.1016/j.jinf.2010.06.001. Epub 2010 Jun 12.

PMID:
20547181
2.

Blood culture time to positivity as a predictor of mortality in community acquired methicillin-susceptible Staphylococcus aureus bacteremia.

Sowden D, Anstey C, Faddy M.

J Infect. 2008 Apr;56(4):295-6. doi: 10.1016/j.jinf.2008.01.005. Epub 2008 Feb 21. No abstract available.

PMID:
18291532
3.

Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.

Khatib R, Riederer K, Saeed S, Johnson LB, Fakih MG, Sharma M, Tabriz MS, Khosrovaneh A.

Clin Infect Dis. 2005 Sep 1;41(5):594-8. Epub 2005 Jul 22.

PMID:
16080079
4.

Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.

Mylotte JM, Tayara A.

Clin Infect Dis. 2000 Nov;31(5):1170-4. Epub 2000 Nov 7.

PMID:
11073748
5.

Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.

Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, Kluytmans J, Bonten M; European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group.

Clin Infect Dis. 2009 Oct 1;49(7):997-1005. doi: 10.1086/605555.

PMID:
19719417
6.
7.

Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.

Paul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, Samra Z, Paghis D, Bishara J, Leibovici L.

J Antimicrob Chemother. 2010 Dec;65(12):2658-65. doi: 10.1093/jac/dkq373. Epub 2010 Oct 14. Review.

PMID:
20947620
8.

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW.

Clin Infect Dis. 2003 Sep 15;37(6):794-9. Epub 2003 Aug 23.

PMID:
12955640
9.

Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.

Lesse AJ, Mylotte JM.

Am J Infect Control. 2006 Dec;34(10):642-50.

PMID:
17161739
10.

Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

Laupland KB, Ross T, Gregson DB.

J Infect Dis. 2008 Aug 1;198(3):336-43. doi: 10.1086/589717.

PMID:
18522502
11.

Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system.

Schønheyder HC, Gottschau A, Friland A, Rosdahl VT.

Scand J Infect Dis. 1995;27(1):19-21.

PMID:
7784808
12.

[Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].

Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, Woehrmann A, Fätkenheuer G, Salzberger B, Kern WV.

Dtsch Med Wochenschr. 2008 Feb;133(8):340-5. doi: 10.1055/s-2008-1046715. German.

PMID:
18270913
13.

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2008 Jan;52(1):192-7. Epub 2007 Nov 5.

14.

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.

Lodise TP, McKinnon PS.

Diagn Microbiol Infect Dis. 2005 Jun;52(2):113-22.

PMID:
15964499
15.

Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer.

González-Barca E, Carratalà J, Mykietiuk A, Fernández-Sevilla A, Gudiol F.

Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):117-9.

PMID:
11305464
16.

Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.

Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U.

Clin Microbiol Infect. 2006 Apr;12(4):345-52.

17.

Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study.

Mihu CN, Schaub J, Kesh S, Jakubowski A, Sepkowitz K, Pamer EG, Papanicolaou GA.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1429-33. doi: 10.1016/j.bbmt.2008.09.005.

18.

Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia.

Choi SH, Chung JW.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):2963-7. doi: 10.1007/s10096-012-1648-0. Epub 2012 May 27.

PMID:
22644058
19.

Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.

Khatib R, Johnson LB, Sharma M, Fakih MG, Ganga R, Riederer K.

Scand J Infect Dis. 2009;41(1):4-9. doi: 10.1080/00365540802441711.

PMID:
18821135
20.

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia.

Hsu MS, Huang YT, Hsu HS, Liao CH.

Clin Microbiol Infect. 2014 Sep;20(9):892-8. doi: 10.1111/1469-0691.12608. Epub 2014 Mar 24.

Supplemental Content

Support Center